Japanese and non-Japanese patient outcomes in the PLATINUM randomized trial comparing the PROMUS Element and XIENCE V everolimus-eluting stents

Journal of Cardiology

Volumn 64, Issue 2, 2014, Pages 105-112

  Saito, Shigeru ^a   Hagiwara, Nobuhisa ^b   Seki, Atsushi ^c   Igarashi, Keiichi ^d   Muramatsu, Toshiya ^e   Yajima, Junji ^f   Yokoi, Hiroyoshi ^g   Nakamura, Masato ^h   Fujii, Kenshi ⁱ   Isshiki, Takaaki ^j   Stone, Gregg W ^k   Teirstein, Paul S ^l   Meredith, Ian T ^m   Allocco, Dominic J ⁿ   Dawkins, Keith D ⁿ  

^a SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

^b TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

^c SAKAKIBARA HEART INSTITUTE   (Japan)

^d Hokkaido Social Insurance Hospital   (Japan)

^e SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^f THE CARDIOVASCULAR INSTITUTE   (Japan)

^g KOKURA MEMORIAL HOSPITAL   (Japan)

^h TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

ⁱ Sakurabashi Watanabe Hospital   (Japan)

^j TEIKYO UNIVERSITY HOSPITAL   (Japan)

^k Department of Medicine   (United States)

^l SCRIPPS CLINIC   (United States)

^m MONASH MEDICAL CENTRE   (Australia)

ⁿ BOSTON SCIENTIFIC CORPORATION   (United States)

more..

Author keywords

Angina pectoris; Clinical trial; Revascularization; Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; PRASUGREL; TICLOPIDINE; ANTITHROMBOCYTIC AGENT; CHROMIUM DERIVATIVE; PLATINUM DERIVATIVE; RAPAMYCIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE SAFETY; DRUG ELUTING STENT; ETHNIC GROUP; FEMALE; FLUOROSCOPY; HUMAN; JAPAN; JAPANESE (PEOPLE); LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; STENT THROMBOSIS; ANALOGS AND DERIVATIVES; ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT ANALYSIS; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMIUM ALLOYS; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATINUM COMPOUNDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIROLIMUS; TREATMENT OUTCOME;

EID: 84905565754     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.12.003     Document Type: Article

References (21)

1. Kimura T., Morimoto T., Nakagawa Y., Kawai K., Miyazaki S., Muramatsu T., Shiode N., Namura M., Sone T., Oshima S., Nishikawa H., Hiasa Y., Hayashi Y., Nobuyoshi M., Mitsudo K. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: Five-year outcome of the j-Cypher Registry. Circulation 2012, 125:584-591.
2. Stone G.W., Ellis S.G., Colombo A., Grube E., Popma J.J., Uchida T., Bleuit J.S., Dawkins K.D., Russell M.E. Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS clinical trial program. J Am Coll Cardiol Interv 2011, 4:530-542.
3. Schwietz T., Ehrlich J.R., De Rosa S., Fichtlscherer S., Schächinger V., Baier G., Laskowski R., Zeiher A.M., Spyridopoulos I., Lehmann R. Prognostic impact of using drug-eluting-stents on outcome and strategy in multivessel PCI: data from the Frankfurt MV-PCI registry. J Cardiol 2013, 61:38-43.
4. Ishihara M., Sato H. Thirty years trend in acute myocardial infarction undergoing coronary angiography at a tertiary emergency center in Japan. J Cardiol 2012, 59:243-248.
5. Stone G.W., Rizvi A., Sudhir K., Newman W., Applegate R.J., Cannon L.A., Maddux J.T., Cutlip D.E., Simonton C.A., Sood P., Kereiakes D.J. Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol 2011, 58:19-25.
6. Stone G.W., Teirstein P.S., Meredith I.T., Farah B., Dubois C.L., Feldman R.L., Dens J., Hagiwara N., Allocco D.J., Dawkins K.D. A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial. J Am Coll Cardiol 2011, 57:1700-1708.
7. Menown I.B., Noad R., Garcia E.J., Meredith I. The platinum chromium element stent platform: from alloy, to design, to clinical practice. Adv Ther 2010, 27:129-141.
8. Stone G.W., Teirstein P.S., Meredith I.T., Bouchard A., Carrié D., Möllmann H., Oldroyd K., Hall J., Allocco D.J., Dawkins K.D. Two-year results of the PLATINUM randomized trial comparing platinum chromium PROMUS element and cobalt chromium PROMUS/XIENCE V everolimus-eluting stents in de novo coronary artery lesions. J Am Coll Cardiol 2012, E323. [abstract; accessed 15.01.13]. 10.1016/S0735-1097(12)60324-6.
9. Ikari Y., Kotani J., Kozuma K., Kyo E., Nakamura M., Yokoi H. Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low dose ticlopidine administration: one year results from CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS). Circ J 2009, 73:1038-1044.
10. Nakamura M., Kotani J., Kozuma K., Uchida T., Iwabuchi M., Muramatsu T., Hirayama H., Fujii K., Saito S. Effectiveness of paclitaxel-eluting stents in complex clinical patients. Insights from the TAXUS Japan Postmarket surveillance study. Circ J 2011, 75:2573-2580.
11. Horiguchi H., Yasunaga H., Hashimoto H., Matsuda S. Impact of drug-eluting stents on treatment option mix for coronary artery disease in Japan. Circ J 2010, 74:1635-1643.
12. Ishikawa T., Nakano Y., Endoh A., Kubota T., Suzuki T., Nakata K., Miyamoto T., Murakami M., Sakamoto H., Imai K., Mochizuki S., Yoshimura M., Mutoh M. Significantly lower incidence of early definite stent thrombosis of drug-eluting stents after unrestricted use in Japan using ticlopidine compared to western countries using clopidogrel: a retrospective comparison with western mega-studies. J Cardiol 2009, 54:238-244.
13. Shimohama T., Ako J., Yamasaki M., Otake H., Tsujino I., Hasegawa T., Nakatani D., Sakurai R., Chang H., Kusano H., Waseda K., Honda Y., Stone G.W., Saito S., Fitzgerald P.J., et al. SPIRIT III JAPAN versus SPIRIT III USA: a comparative intravascular ultrasound analysis of the everolimus-eluting stent. Am J Cardiol 2010, 106:13-17.
14. Marx S.O., Marks A.R. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 2001, 104:852-855.
15. O'Brien B.J., Stinson J.S., Larsen S.R., Eppihimer M.J., Carroll W.M. A platinum-chromium steel for cardiovascular stents. Biomaterials 2010, 31:3755-3761.
16. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115:2344-2351.
17. De la Torre Hernandez J., Garcia Camarero T., Lerena P., Lee D.-H., Sainz Laso F., Frances Santamaria V., Fernandez Menendez M., Martin Gorria G., Zueco J. An all comers randomized trial comparing Xience Prime and Promus Element Stents: preliminary results. J Am Coll Cardiol 2011, 58:B68. [abstract].
18. Li R., Low A.F., Lee C.H., Chan M., Teo S.G., Chan K.H., Richards A.M., Tan H.C. Real-world comparison of clinical outcomes of patients who received new generation platinum chromium everolimus-eluting stent versus cobalt chromium everolimus-eluting stent. J Am Coll Cardiol 2011, 58:B55. [abstract].
19. Meredith I.T., Whitbourn R., Scott D., El-Jack S., Zambahari R., Stone G.W., Teirstein P.S., Starzyk R.M., Allocco D.J., Dawkins K.D. PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses. EuroIntervention 2011, 7:84-90.
20. Saito S., Iwabuchi M., Muramatsu T., Namiki A., Matsumura T., Igarashi K., Yajima J., Nakamura S., Allocco D.J., Dawkins K.D. PLATINUM Japan SV: platinum chromium everolimus-eluting stent in small vessels. Cardiovasc Revasc Med 2012, 13:147-148. [abstract].
21. Mutoh M., Ishikawa T., Hasuda T., Okada H., Endo A., Miyanaga S., Higashitani M., Nakano Y., Kubota T., Nakata K., Nagoshi T., Hayashi M., Sakamoto H., Oota M., Imai K., et al. Predictors of target lesion revascularization and documented stent thrombosis beyond 30 days after sirolimus-eluting stent implantation: retrospective analysis in consecutive 1,070 angiographic follow-up lesions. Circ J 2007, 71:1328-1331.